Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FHKX1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,792
Award facts
- Contract value 100% obligated
- $15,792.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,792.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/mL syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of February 17, 2026, and was awarded on January 26, 2026. No set-aside designation was used in this award. DMS Pharmaceutical Group Inc. serves as the prime contractor with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical consumable support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a regional prime vendor contractor reflects its demonstrated capability to supply diverse pharmaceutical products, including branded and generic medications, biologics, and specialty pharmaceuticals essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FHKX1?
SPE2DR26FHKX1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FHKX1 worth?
The government has obligated $15,792 on SPE2DR26FHKX1.
Is contract SPE2DR26FHKX1 an order under another contract?
Yes. SPE2DR26FHKX1 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKX1 competed?
The extent of competition for SPE2DR26FHKX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award